High pretreatment miR-181a-1 and/or miR-181a-2 expression in intermediate risk acute myeloid leukemia (AML) patients (pts) associates with lower relapse rates after reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT)
ONKOLOGIE（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要